Bristol-Myers Squibb Company
BMY
$49.02
$0.5551.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 120.62% | -95.91% | -37.19% | -18.96% | -626.57% |
| Total Depreciation and Amortization | -74.22% | -24.50% | 6.47% | 7.23% | 5.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.03% | 252.58% | -31.67% | 145.12% | 3,705.41% |
| Change in Net Operating Assets | -1,044.95% | 49.24% | 486.60% | -39.47% | 114.56% |
| Cash from Operations | -31.05% | 4.40% | 17.68% | 23.26% | -4.58% |
| Capital Expenditure | 8.45% | -14.55% | 5.26% | -1.16% | -2.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.61% | 91.91% | -6.75% | -646.20% | -25,608.97% |
| Divestitures | 0.83% | 38.17% | 3.24% | 39.18% | 6.17% |
| Other Investing Activities | -184.52% | 84.62% | 1,700.00% | 157.50% | 690.12% |
| Cash from Investing | 97.46% | 85.44% | 46.59% | -300.91% | -9,241.90% |
| Total Debt Issued | -97.69% | -109.59% | 1,050.00% | 183.48% | 12,363.28% |
| Total Debt Repaid | -- | 100.00% | -- | -1,207.95% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.80% | -5.00% | -2.10% | -1.67% | -1.34% |
| Other Financing Activities | -6.19% | -- | -58.97% | -111.32% | -5.43% |
| Cash from Financing | -106.78% | -269.80% | 25.35% | -85.14% | 580.13% |
| Foreign Exchange rate Adjustments | 246.67% | -288.46% | 302.63% | -175.00% | -446.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.16% | -37.89% | 286.35% | -387.64% | -688.81% |